Boisvert, W. et al., "Mechanisms of Action of Chloroalanyl Antibacterial Peptides" J. Biol. Chem. 261(17):7871-7878 (1986). |
Huber, B.E. and Richards, C.A., "Regulated Expression of Artificial Chimeric Genes Contained in Retroviral Vectors: Implications for Virus Directed Enzyme Prodrug Therapy (VDEPT) and Other Gene Therapy Applications" J. Drug Targeting 3:349-356 (1996). |
Kerr, D.E. et al., "Regressions and cures of melanoma xenografts following treatment with monoclonal antibody .beta.-lactamase conjugates in combination with anticancer prodrugs" Cancer Res. 55(16):3558-3563 (1995). |
Maher, M. et al., "The sensitive detection of fluorescently labelled PCR products using an automated detection system" Mol. Cell. Probes 9:265-276 (1995). |
Melton, R.G. and Sherwood, R.F., "Antibody-Enzyme Conjugates for Cancer Therapy" J. Natl. Cancer Inst. 88(3/4):153-165 (1996). |
Meyer, D.L. et al., "Preparation and characterization of a .beta.-lactamase-Fab' conjugate for the site-specific activation of oncolytic agents" Bioconjugate Chem. 3(1):42-48 (1992). |
Mobashery, S. et al., "Conscripting .beta.-Lactamase for Use in Drug Delivery, Synthesis and Biological Activity of a Cephalosporin C.sub.10 -Ester of an Antibiotic Peptide" J. Am. Chem. Soc. 108:1685 (1986). |
Murray, B.E., "Antibiotic Resistance" Adv. Int. Med. 42:339-367 (1997). |
Rodrigues, M.L. et al., "Synthesis and .beta.-lactamase-mediated activation of a cephalosporin-taxol prodrug" Chemistry & Biology 2:223-227 (1995). |
Smyth, T.P., "S-Aminosulfeniminopenicillins: Multimode .beta.-Lactamase Inhibitors and Template Structures for Penicillin-Based .beta.-Lactamase Substrates as Prodrugs" J. Org. Chem. 63:7600-7618 (1998). |
Steinberg, J.P. et al., "Nosocomial and Community-Acquired Staphylococcus aureus Bacteremias from 1980 to 1993: Impact of Intracascular Devices and Methicillin Resistance" Clin. Infect. Dis. 23:255-259 (1996). |
Stosor, V. et al, The Management and Prevention of Vancomycin-Resistant Enterococci Infect Med 13(6):487-488,493-498 (1996). |
Straus, S.E., "Strategies To Combat Viral Infections" in: Microbial Disease, 3.sup.rd Edition, Schaechter et al., eds., Williams & Wilkins, Baltimore, MD, Chapter 43, pp. 403-411 (1998). |
Takasuka, T. et al., "Variation in Morphotype, Karyotype and DNA Type of Fluconazole Resistant Candida albicans from an AIDS Patient" J. Infection 36(1):57-62 (1998). |
Vrudhula, V.M. et al., "Cephalosporin Derivatives of Doxorubicin as Prodrugs for Activation by Monoclonal Antibody-.beta.-Lactamase Conjugates" J. Med. Chem. 38:1380-1385 (1995). |
Bush, K., ".beta.-Lactamase Inhibitors from Laboratory to Clinic" Clin. Microb. Rev. 1(1):109-123 (1988). |
Kondo, H. et al., "Studies on Prodrugs. 7. Synthesis and Antimicrobial Activity of 3-Formylquinolone Derivatives" J. Med. Chem. 31:221-225 (1988). |
Mobashery, S. and Johnston, M., "Reactions of Escherichia coli TEM .beta.-Lactamase with Cephalothin and with C.sub.10 -Dipeptidyl Cephalosporin Esters" J. Biol. Chem. 261(17):7879-7887 (1986). |